Masayuki Aoki

Years Active: 2020-2020
Publications (10 Years): 1

Medical Corporation Takeshita Naika

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical Corporation Takeshita Naika Jan 01 2020

Japan

Chief Director

Publications

Shin Nishio, Koji Matsumoto, Kazuhiro Takehara, Naoki Kawamura, Kosei Hasegawa, Nobuhiro Takeshima, Daisuke Aoki, Shoji Kamiura, Atsushi Arakawa, Eiji Kondo, Tomoko Hirakawa, Keiko Yamamoto, Masayuki Aoki, Karen Stein, Stephen Keefe, Keiichi Fujiwara, Kimio Ushijima
Pembrolizumab monotherapy in Japanese patients with advanced ovarian cancer: Subgroup analysis from the KEYNOTE-100. Cancer science 111 (4) (2020)

Masayuki Aoki.css-eqlu8i{font-size:small;padding-left:4px;}